Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment

INTRODUCTION: Methimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Daniela, Bruno, Antonino, Gallazzi, Matteo, Cattaneo, Simona Antonia Maria, Veronesi, Giovanni, Genoni, Angelo, Tanda, Maria Laura, Bartalena, Luigi, Passi, Alberto, Piantanida, Eliana, Mortara, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141462/
https://www.ncbi.nlm.nih.gov/pubmed/37124743
http://dx.doi.org/10.3389/fendo.2023.1145811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141462/
https://www.ncbi.nlm.nih.gov/pubmed/37124743
http://dx.doi.org/10.3389/fendo.2023.1145811

Ejemplares similares